Resveratrol induces mitochondrial respiration and apoptosis in SW620 colon cancer cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1861, Issue 2, 2017, Pages 431-440

  Blanquer Rosselló, Mª del Mar ^a,b,c   Hernández López, Reyniel ^a,b,c   Roca, Pilar ^a,b,c   Oliver, Jordi ^a,b,c   Valle, Adamo ^a,b,c  

^a Instituto Universitario de Investigación en Ciencias de la Salud IUNICS   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Apoptosis; Colon cancer; Metabolism; Mitochondria; Resveratrol; SW620

Indexed keywords

ADENOSINE TRIPHOSPHATE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; RESVERATROL; FATTY ACID; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL METABOLISM; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; DRUG CYTOTOXICITY; DRUG TARGETING; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOLECULAR BIOLOGY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; WESTERN BLOTTING; CALORIC RESTRICTION; CELL RESPIRATION; COLON; COLONIC NEOPLASMS; DRUG EFFECTS; ENERGY METABOLISM; GLYCOLYSIS; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION; PROCEDURES; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; CALORIC RESTRICTION; CELL LINE, TUMOR; CELL RESPIRATION; COLON; COLONIC NEOPLASMS; ENERGY METABOLISM; FATTY ACIDS; GLYCOLYSIS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 85006100844     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2016.10.009     Document Type: Article

References (42)

1. [1] Burns, J., Yokota, T., Ashihara, H., Lean, M.E., Crozier, A., Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 50:11 (May 22 2002), 3337–3340.
2. [2] Varoni, E.M., Lo Faro, A.F., Sharifi-Rad, J., Iriti, M., Anticancer molecular mechanisms of resveratrol. Front. Nutr., 3, 2016, 8.
3. [3] Aluyen, J.K., Ton, Q.N., Tran, T., Yang, A.E., Gottlieb, H.B., Bellanger, R.A., Resveratrol: potential as anticancer agent. J. Diet. Suppl. 9:1 (Mar 2012), 45–56.
4. [4] Juan, M.E., Alfaras, I., Planas, J.M., Colorectal cancer chemoprevention by trans-resveratrol. Pharmacol. Res. 65:6 (Jun 2012), 584–591.
5. [5] Yang, T., Wang, L., Zhu, M., Zhang, L., Yan, L., Properties and molecular mechanisms of resveratrol: a review. Pharmazie 70:8 (Aug 2015), 501–506.
6. [6] Walle, T., Hsieh, F., DeLegge, M.H., Oatis, J.E. Jr., Walle, U.K., High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32:12 (Dec 2004), 1377–1382.
7. [7] Li, Z.G., Hong, T., Shimada, Y., Komoto, I., Kawabe, A., Ding, Y., et al. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23:9 (Sep 2002), 1531–1536.
8. [8] Tessitore, L., Davit, A., Sarotto, I., Caderni, G., Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21:8 (Aug 2000), 1619–1622.
9. [9] Patel, K.R., Brown, V.A., Jones, D.J., Britton, R.G., Hemingway, D., Miller, A.S., et al. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70:19 (Oct 1 2010), 7392–7399.
10. [10] Chung, J.H., Manganiello, V., Dyck, J.R., Resveratrol as a calorie restriction mimetic: therapeutic implications. Trends Cell Biol. 22:10 (Oct 2012), 546–554.
11. [11] de Oliveira, M.R., Nabavi, S.F., Manayi, A., Daglia, M., Hajheydari, Z., Nabavi, S.M., Resveratrol and the mitochondria: from triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochim. Biophys. Acta 1860:4 (Apr 2016), 727–745.
12. [12] Valdecantos, M.P., Perez-Matute, P., Quintero, P., Martinez, J.A., Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different. Redox Rep. 15:5 (2010), 207–216.
13. [13] Zheng, J., Ramirez, V.D., Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals. Br. J. Pharmacol. 130:5 (Jul 2000), 1115–1123.
14. [14] Kim, S.K., Joe, Y., Zheng, M., Kim, H.J., Yu, J.K., Cho, G.J., et al. Resveratrol induces hepatic mitochondrial biogenesis through the sequential activation of nitric oxide and carbon monoxide production. Antioxid. Redox Signal. 20:16 (Jun 1 2014), 2589–2605.
15. [15] Zini, R., Morin, C., Bertelli, A., Bertelli, A.A., Tillement, J.P., Effects of resveratrol on the rat brain respiratory chain. Drugs Exp. Clin. Res. 25:2-3 (1999), 87–97.
16. [16] Warburg, O., On the origin of cancer cells. Science 123:3191 (Feb 24 1956), 309–314.
17. [17] Kueck, A., Opipari, A.W. Jr., Griffith, K.A., Tan, L., Choi, M., Huang, J., et al. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol. Oncol. 107:3 (Dec 2007), 450–457.
18. [18] Gomez, L.S., Zancan, P., Marcondes, M.C., Ramos-Santos, L., Meyer-Fernandes, J.R., Sola-Penna, M., et al. Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie 95:6 (Jun 2013), 1336–1343.
19. [19] Gwak, H., Haegeman, G., Tsang, B.K., Song, Y.S., Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cells. Mol. Carcinog. 54:12 (Dec 2015), 1529–1540.
20. [20] Nagamine, M.K., da Silva, T.C., Matsuzaki, P., Pinello, K.C., Cogliati, B., Pizzo, C.R., et al. Cytotoxic effects of butanolic extract from Pfaffia paniculata (Brazilian ginseng) on cultured human breast cancer cell line MCF-7. Exp. Toxicol. Pathol. 61:1 (Jan 2009), 75–82.
21. [21] Chrzanowska-Lightowlers, Z.M., Turnbull, D.M., Lightowlers, R.N., A microtiter plate assay for cytochrome c oxidase in permeabilized whole cells. Anal. Biochem. 214:1 (Oct 1993), 45–49.
22. [22] Brand, M.D., Nicholls, D.G., Assessing mitochondrial dysfunction in cells. Biochem. J. 435:2 (Apr 15 2011), 297–312.
23. [23] Kelly, D.P., Scarpulla, R.C., Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18:4 (Feb 15 2004), 357–368.
24. [24] Li, X., Kazgan, N., Mammalian sirtuins and energy metabolism. Int. J. Biol. Sci. 7:5 (2011), 575–587.
25. [25] Chen, J.Q., Brown, T.R., Russo, J., Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim. Biophys. Acta 1793:7 (Jul 2009), 1128–1143.
26. [26] Sack, M.N., Finkel, T., Mitochondrial metabolism, sirtuins, and aging. Cold Spring Harb. Perspect. Biol., 4(12), Dec 2012.
27. [27] Csiszar, A., Labinskyy, N., Pinto, J.T., Ballabh, P., Zhang, H., Losonczy, G., et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 297:1 (Jul 2009), H13–H20.
28. [28] Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:6 (Dec 15 2006), 1109–1122.
29. [29] Sugiyama, M., Kawahara-Miki, R., Kawana, H., Shirasuna, K., Kuwayama, T., Iwata, H., Resveratrol-induced mitochondrial synthesis and autophagy in oocytes derived from early antral follicles of aged cows. J. Reprod. Dev. 61:4 (2015), 251–259.
30. [30] Prabhu, V., Srivastava, P., Yadav, N., Amadori, M., Schneider, A., Seshadri, A., et al. Resveratrol depletes mitochondrial DNA and inhibition of autophagy enhances resveratrol-induced caspase activation. Mitochondrion 13:5 (Sep 2013), 493–499.
31. [31] Kincaid, B., Bossy-Wetzel, E., Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration. Front. Aging Neurosci., 5, 2013, 48.
32. [32] Desquiret-Dumas, V., Gueguen, N., Leman, G., Baron, S., Nivet-Antoine, V., Chupin, S., et al. Resveratrol induces a mitochondrial complex I-dependent increase in NADH oxidation responsible for sirtuin activation in liver cells. J. Biol. Chem. 288:51 (Dec 20 2013), 36662–36675.
33. [33] Gehm, B.D., McAndrews, J.M., Chien, P.Y., Jameson, J.L., Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. U. S. A. 94:25 (Dec 9 1997), 14138–14143.
34. [34] Bowers, J.L., Tyulmenkov, V.V., Jernigan, S.C., Klinge, C.M., Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 141:10 (Oct 2000), 3657–3667.
35. [35] Beauvieux, M.C., Stephant, A., Gin, H., Serhan, N., Couzigou, P., Gallis, J.L., Resveratrol mainly stimulates the glycolytic ATP synthesis flux and not the mitochondrial one: a saturation transfer NMR study in perfused and isolated rat liver. Pharmacol. Res. 78 (Dec 2013), 11–17.
36. [36] Aires, V., Delmas, D., Le Bachelier, C., Latruffe, N., Schlemmer, D., Benoist, J.F., et al. Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts. Orphanet J. Rare Dis., 9, 2014, 79.
37. [37] Rosca, M.G., Vazquez, E.J., Chen, Q., Kerner, J., Kern, T.S., Hoppel, C.L., Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes 61:8 (Aug 2012), 2074–2083.
38. [38] Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114:12 (Dec 2004), 1752–1761.
39. [39] Samudio, I., Fiegl, M., McQueen, T., Clise-Dwyer, K., Andreeff, M., The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation. Cancer Res. 68:13 (Jul 1 2008), 5198–5205.
40. [40] Lin, H.Y., Tang, H.Y., Davis, F.B., Davis, P.J., Resveratrol and apoptosis. Ann. N. Y. Acad. Sci. 1215 (Jan 2011), 79–88.
41. [41] Zhou, J.H., Cheng, H.Y., Yu, Z.Q., He, D.W., Pan, Z., Yang, D.T., Resveratrol induces apoptosis in pancreatic cancer cells. Chin. Med. J. 124:11 (Jun 2011), 1695–1699.
42. [43] Santandreu, F.M., Valle, A., Oliver, J., Roca, P., Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell. Physiol. Biochem. 28:2 (2011), 219–228.